These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18987297)

  • 1. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.
    Fishbane S; Pollack S; Feldman HI; Joffe MM
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):57-61. PubMed ID: 18987297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
    Ferrari P; Mallon D; Trinder D; Olynyk JK
    Nephrology (Carlton); 2010 Apr; 15(3):344-9. PubMed ID: 20470305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R; Kalantar-Zadeh K
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing iron status: beyond serum ferritin and transferrin saturation.
    Wish JB
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
    Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    McFarlane SI; Chen SC; Whaley-Connell AT; Sowers JR; Vassalotti JA; Salifu MO; Li S; Wang C; Bakris G; McCullough PA; Collins AJ; Norris KC;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S46-55. PubMed ID: 18359408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
    Wikström B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL
    J Nephrol; 2011; 24(5):589-96. PubMed ID: 21240875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
    McMahon LP; Kent AB; Kerr PG; Healy H; Irish AB; Cooper B; Kark A; Roger SD
    Nephrol Dial Transplant; 2010 Mar; 25(3):920-6. PubMed ID: 19906658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
    Stancu S; Bârsan L; Stanciu A; Mircescu G
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):409-16. PubMed ID: 20019121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.
    Besarab A; Dalton CL
    Nephrol Nurs J; 2001 Aug; 28(4):429-34. PubMed ID: 12143465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentration of ferritin, transferrin and iron as a markers of iron deficiency in healthy women in reproductive age].
    Chełchowska M; Laskowska-Klita T; Leibschang J
    Pol Merkur Lekarski; 2007 Jan; 22(127):25-7. PubMed ID: 17477085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron status of the Taiwanese elderly: the prevalence of iron deficiency and elevated iron stores.
    Wang JL; Shaw NS
    Asia Pac J Clin Nutr; 2005; 14(3):278-84. PubMed ID: 16169840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.
    Shan Y; Lambrecht RW; Bonkovsky HL
    Clin Infect Dis; 2005 Mar; 40(6):834-41. PubMed ID: 15736017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
    Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS
    Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of iron deficiency in heart and kidney allograft recipients.
    Przybylowski P; Malyszko J; Glowinska I; Malyszko J; Kozlowska S; Mysliwiec M
    Transplant Proc; 2011 Dec; 43(10):3885-7. PubMed ID: 22172865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
    J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.